Related references
Note: Only part of the references are listed.Early morphological changes in cardiac mitochondria after subcutaneous administration of trastuzumab in rabbits: possible prevention with oral selenium supplementation
Heather S. Laird-Fick et al.
CARDIOVASCULAR PATHOLOGY (2020)
Body Composition, Adherence to Anthracycline and Taxane-Based Chemotherapy, and Survival After Nonmetastatic Breast Cancer
Elizabeth M. Cespedes Feliciano et al.
JAMA ONCOLOGY (2020)
Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction
Biniyam G. Demissei et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement
Ian J. Neeland et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Adipose Tissue Distribution and Cardiovascular Disease Risk Among Breast Cancer Survivors
Elizabeth M. Cespedes Feliciano et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity
Monica Samuel Avila et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101-Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity
Edith Pituskin et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study
Geeta Gulati et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Longitudinal assessment of right ventricular structure and function by cardiovascular magnetic resonance in breast cancer patients treated with trastuzumab: a prospective observational study
Ashita Barthur et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2017)
GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective
Ramu Adela et al.
JOURNAL OF DIABETES RESEARCH (2015)
Reference Intervals for Insulin-like Growth Factor-1 (IGF-I) From Birth to Senescence: Results From a Multicenter Study Using a New Automated Chemiluminescence IGF-I Immunoassay Conforming to Recent International Recommendations
Martin Bidlingmaier et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Myocardial matrix metalloproteinase-2: inside out and upside down
Ashley DeCoux et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab
Bonnie Ky et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Saturation Recovery Single-Shot Acquisition (SASHA) for Myocardial T1 Mapping
Kelvin Chow et al.
MAGNETIC RESONANCE IN MEDICINE (2014)
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Juan Carlos Plana et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2014)
Intermuscular and intramuscular adipose tissues: Bad vs. good adipose tissues
Gary J. Hausman et al.
ADIPOCYTE (2014)
Left and right ventricular effects of anthracycline and trastuzumab chemotherapy: A prospective study using novel cardiac imaging and biochemical markers
Suchi Grover et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Circulating Neuregulin During the Transition From Stage A to Stage B/C Heart Failure in a Breast Cancer Cohort
Carrie A. Geisberg et al.
JOURNAL OF CARDIAC FAILURE (2013)
Neuregulin in Cardiovascular Development and Disease
Oghenerukevwe Odiete et al.
CIRCULATION RESEARCH (2012)
Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
Heloisa Sawaya et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2012)
Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101-Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzumab-mediated left ventricular remodeling among patients with HER2+early breast cancer using cardiac MRI
Edith Pituskin et al.
BMC CANCER (2011)
Novel Toll-like receptor-4 deficiency attenuates trastuzumab (Herceptin) induced cardiac injury in mice
Nasser Ghaly Yousif et al.
BMC CARDIOVASCULAR DISORDERS (2011)
Circulating levels of IGF1 are associated with muscle strength in middle-aged- and oldest-old women
Diana G. Taekema et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Meta-Analysis and Dose-Response Metaregression: Circulating Insulin-Like Growth Factor I (IGF-I) and Mortality
Anne Marij G. Burgers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care
Marina Mourtzakis et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2008)
Trastuzumab in the adjuvant treatment of early-stage breast cancer: A systematic review and meta-analysis of randomized controlled trials
Issa J. Dahabreh et al.
ONCOLOGIST (2008)
Cardiotoxicity of trastuzumab in clinical practice
Heather L. McArthur et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Share Paper
